Select A Category

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

Nevoral
September 25, 2026

Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a...

Articles for tag: After, capital-markets